Tivic Health Systems Inc (TIVC) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Tivic Health Systems Inc stock (TIVC) is currently trading at $1.02. Tivic Health Systems Inc PS ratio (Price-to-Sales) is 5.34. Analyst consensus price target for TIVC is $210.00. WallStSmart rates TIVC as Sell.
- TIVC PE ratio analysis and historical PE chart
- TIVC PS ratio (Price-to-Sales) history and trend
- TIVC intrinsic value — DCF, Graham Number, EPV models
- TIVC stock price prediction 2025 2026 2027 2028 2029 2030
- TIVC fair value vs current price
- TIVC insider transactions and insider buying
- Is TIVC undervalued or overvalued?
- Tivic Health Systems Inc financial analysis — revenue, earnings, cash flow
- TIVC Piotroski F-Score and Altman Z-Score
- TIVC analyst price target and Smart Rating
Tivic Health Systems Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Tivic Health Systems Inc (TIVC) · 7 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Tivic Health Systems Inc (TIVC) Key Strengths (1)
Trading below book value, meaning the market prices it less than net assets
Supporting Valuation Data
Tivic Health Systems Inc (TIVC) Areas to Watch (6)
Company is destroying shareholder value
Losing money on operations
Very low institutional interest at 9.13%
Micro-cap company with very limited liquidity and high volatility
Premium valuation at 5.3x annual revenue
Solid revenue growth at 15.90% per year
Supporting Valuation Data
Tivic Health Systems Inc (TIVC) Detailed Analysis Report
Overall Assessment
This company scores 27/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 1 register as strengths (avg 10.0/10) while 6 fall into concern territory (avg 2.5/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book. Valuation metrics including Price/Book (0.46) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Institutional Own.. Some valuation metrics including Price/Sales (5.34) suggest expensive pricing. Growth concerns include Revenue Growth at 15.90%, which may limit upside. Profitability pressure is visible in Return on Equity at -178.20%, Operating Margin at -1701.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -178.20% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 15.90% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
TIVC Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
TIVC's Price-to-Sales ratio of 5.34x sits near its historical average of 5.05x (77th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 85% below its historical high of 34.85x set in Apr 2025, and 5833% above its historical low of 0.09x in Jul 2023. Over the past 12 months, the PS ratio has compressed from ~9.1x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Tivic Health Systems Inc (TIVC) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Tivic Health Systems Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 482,000 with 16% growth year-over-year. The company is currently unprofitable, posting a 0.0% profit margin.
Key Findings
Spending 178% of revenue (858,000) on R&D, reinforcing its commitment to innovation and future growth.
Free cash flow is -2M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Volatility is elevated with a beta of 2.01, so expect amplified moves relative to the broader market.
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Tivic Health Systems Inc.
Bottom Line
Tivic Health Systems Inc offers an attractive blend of growth (16% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Tivic Health Systems Inc(TIVC)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
Tivic Health Systems Inc (TIVC) is a pioneering medical technology firm focused on developing non-invasive bioelectronic therapies aimed at addressing chronic conditions, particularly allergic rhinitis. Leveraging its proprietary platform and extensive clinical expertise, Tivic Health is committed to delivering innovative solutions that not only meet critical patient needs but also optimize healthcare delivery. Positioned at the vanguard of the burgeoning bioelectronic medicine landscape, the company is set to seize emerging market opportunities, significantly improving patient outcomes and establishing new benchmarks in chronic condition management.